Case Report: Ischemic stroke in a young transgender woman due to unsupervised estrogen therapy
This case highlights the risks of inappropriate use of gender-affirming hormone therapy and the need for rigorous medical supervision. Given the growing access to this treatment, continuous monitoring is essential to minimize complications. Further research is needed to establish safer guidelines for the use of hormone therapy in the transgender population.
Authors
- Edward Silva (ORCID: https://orcid.org/0000-0002-7254-6307)
- Alisson Araújo (ORCID: https://orcid.org/0000-0002-4623-3745)
- Maria Luiza Ferri Cury
- Antonio Carlos Oliveira (ORCID: https://orcid.org/0000-0003-4673-4803)
- F. Kim
- Rodolfo Corona (ORCID: https://orcid.org/0000-0002-1052-8736)
- Luana Caroline dos Santos (ORCID: https://orcid.org/0000-0001-9836-3704)
- Isabela de Carvalho Florêncio (ORCID: https://orcid.org/0000-0003-2564-4008)
- Amanda Boutrik (ORCID: https://orcid.org/0000-0003-1164-5253)
- Gabriel Pereira Braga
- Renata Gratão Rezende
- L. Silva (ORCID: https://orcid.org/0009-0009-8062-0720)
Institutions
- Universidade Federal de Mato Grosso do Sul (BR)
- Hospital Universitário de Santa Maria (BR)
- Santa Casa de Misericórdia de Marília (BR)
Publication Details
- Journal
- Frontiers in Global Women s Health
- Published
- 2025-08-08
- DOI
- https://doi.org/10.3389/fgwh.2025.1588553
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00